Income Statement
CARDIO DIAGNOSTICS HOLDINGS, INC.
CDIO
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Revenue
|
0.01 | 0.03 | 0.02 | 0.00 | - |
|
Cost of Revenue
|
- | - | - | - | - |
|
Gross Profit
|
0.01 | 0.03 | 0.02 | 0.00 | - |
|
Operating Expenses
|
6.51 | 8.40 | 7.26 | 4.55 | 0.00 |
|
Research & Development
|
0.64 | 0.03 | 0.15 | 0.04 | - |
|
Selling, General & Administrative
|
5.03 | 8.17 | 6.94 | 4.40 | - |
|
Other Operating Expenses
|
- | - | - | - | - |
|
Operating Income
|
-6.50 | -8.37 | -7.24 | -4.55 | - |
|
Non-Operating Income
|
0.00 | 0.02 | 1.13 | 0.11 | - |
|
Interest Income
|
0.00 | 0.00 | 0.00 | - | - |
|
Interest Expense
|
0.01 | 0.02 | 6.74 | - | - |
|
Other Non-Op Income / Expense
|
-0.01 | -0.02 | -1.13 | - | - |
|
Income Before Tax
|
-6.50 | -8.38 | -8.38 | -4.66 | - |
|
Income Tax Expense
|
0.00 | 0.00 | 0.00 | 0.00 | - |
|
Non-Controlling Interest
|
- | - | - | - | - |
|
Net Income
|
-6.50 | -8.38 | -8.38 | -4.66 | - |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - |
|
EBITDA
|
-6.43 | -8.35 | -7.22 | -4.53 | 0.00 |
|
Earnings Per Share (Basic)
|
-3.71 | -0.31 | -0.66 | - | - |
|
Diluted EPS
|
-3.71 | -0.31 | -0.66 | - | - |
|
Weighted Average Shares
|
1.75 | 26.89 | 12.69 | - | - |
|
Diluted Weighted Avg Shares
|
1.75 | 26.89 | 12.69 | - | - |
|
Comprehensive Income
|
- | - | - | - | - |